Search

Search Constraints

You searched for: Author/Creator Lopatin, Yuri

Search Results

1. Antithrombotic and anticoagulation therapies in cardiogenic shock: a critical review of the published literature. (19th October 2021)

2. Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of Cardiology. (5th July 2022)

3. Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology. (21st April 2022)

4. Cardiac remodelling – Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology. (16th May 2022)

5. Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology. (7th September 2022)

6. Corrigendum to "Trimetazidine in cardiovascular medicine, " [Int. J. Cardiol., 293 (2019) 39–44]. (1st December 2020)

7. European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose‐lowering drugs in patients with heart failure. (9th December 2019)

8. Heart Failure Association of the European Society of Cardiology Quality of Care Centres Programme: design and accreditation document. (18th March 2020)

9. Heart Failure Association of the European Society of Cardiology update on sodium–glucose co‐transporter 2 inhibitors in heart failure. (27th October 2020)

10. Heart failure during the COVID‐19 pandemic: clinical, diagnostic, management, and organizational dilemmas. (16th September 2022)